Join FOMAT Medical Research at the 12th Alzheimer’s & Parkinson’s Drug Development Summit this April. We're eager to delve into the latest in AD & PD research, including breakthroughs like Lecanemab. This event is a prime opportunity for networking and discussions on the future of healthcare innovation.
We're part of a select group eager to contribute to this evolving field and look forward to potential collaborations. Connect with Brandon Johnson, our Business Development Specialist, to explore how we can advance patient care and research together. Don’t miss out on this chance to be at the cutting edge of medical research advancements.
Brandon Johnson
Business Development Specialist